Use access key #2 to skip to page content.

comments on Given Imaging



February 12, 2008 – Comments (0)

For quite some time, Given Imaging's Pillcam had significant advantages over the competing product that Olympus was trying to market. The Pillcam was cheaper and produced better images. Now, I am told that Olympus' latest product produces better images. And we all know that Olympus has significant marketing muscle.

On the plus side, the Pillcam is recently undergoing trial in Germany.

However, Given is up against a lot, and the stock has recently taken a significant dive from its highs. I used to be the score leader here, and I'm sad to give it up. However, this proves that technological advantages alone are no gaurantee of success - a fact that Isilon shareholders should realize. I'm not sure that I'd put additional money into Given at this point. However, they have an R&D outfit, and they will be improving their existing products. It's conceivable they could better Olympus again. 

0 Comments – Post Your Own

Featured Broker Partners